Download PDF
Pharmacopsychiatry 2014; 47(04/05): 151-155
DOI: 10.1055/s-0034-1381983
Original Paper
© Georg Thieme Verlag KG Stuttgart · New York

Hypothalamic-Pituitary-Adrenal Axis Response to Oral Naltrexone in Alcoholics during Early Withdrawal

A. Besirli
1   Department of Psychiatry, Şişli Etfal Training and Research Hospital, İstanbul, Turkey
,
E. Eşel
2   Department of Psychiatry, Erciyes University, Kayseri, Turkey
,
S. Özsoy
2   Department of Psychiatry, Erciyes University, Kayseri, Turkey
,
T. Turan
2   Department of Psychiatry, Erciyes University, Kayseri, Turkey
› Author Affiliations
Further Information

Publication History

received 09 February 2014
revised 04 May 2014

accepted 13 May 2014

Publication Date:
17 June 2014 (online)

Also available at
    Permissions and Reprints

Abstract

Introduction: It is thought that naltrexone may play a significant role in the regulation of the hypothalamic-pituitary-adrenal (HPA) axis response to stress. We investigated the HPA axis response following single-dose oral naltrexone administration in the early phase of alcohol withdrawal.

Methods: Cortisol and adrenocorticotrophic hormone (ACTH) responses to naltrexone were measured in alcohol-dependent males (n=23) and in healthy males (n=20). Blood samples were collected for cortisol and ACTH measurements before administering (0 min) 50 mg naltrexone at 08.00 in the morning, and at 60, 90, 120 and 180 min after administering naltrexone.

Results: Naltrexone administration resulted in a significant ACTH response in the patients while cortisol and ACTH responses were found to be significant in the controls. Cortisol response was not large enough to reach significance in the patients. ACTH level changes as a response to naltrexone in the patients were lower than that in the controls.

Discussion: The study revealed blunted cortisol and attenuated ACTH responses to naltrexone in early alcohol withdrawal. This study may have shown impairment in adrenal and pituitary levels during alcohol withdrawal.

Key words

Naltrexone - HPA axis - cortisol - ACTH - alcohol withdrawal
 

  • References

  • 1 King AC, Schluger J, Gunduz M et al. Hypothalamic-pituitary-adrenocortical (HPA) axis response and biotransformation of oral naltrexone: preliminary examination of relationship to family history of alcoholism. Neuropsychopharmacology 2002; 26: 778-788
    CrossrefPubMedSearch in Google Scholar
  • 2 Naber D, Pickar D, Davis GC et al. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Psychopharmacology (Berl) 1981; 74: 125-128
    CrossrefPubMedSearch in Google Scholar
  • 3 Kreek MJ, Schaefer RA, Hahn EF et al. Naloxone, a specific opioid antagonist, reverses chronic idiopathic constipation. Lancet 1983; 1: 261-262
    PubMedSearch in Google Scholar
  • 4 Cohen MR, Cohen RM, Pickar D et al. High-dose naloxone infusions in normals. Dose-dependent behavioral, hormonal, and physiological responses. Arch Gen Psychiatry 1983; 40: 613-619
    CrossrefPubMedSearch in Google Scholar
  • 5 Conaglen JV, Donald RA, Espiner EA et al. Effect of naloxone on the hormone response to CRF in normal man. Endocr Res 1985; 11: 39-44
    CrossrefPubMedSearch in Google Scholar
  • 6 Delitala G, Trainer PJ, Oliva O et al. Opioid peptide and alpha-adrenoceptor pathways in the regulation of the pituitary-adrenal axis in man. J Endocrinol 1994; 141: 163-168
    CrossrefPubMedSearch in Google Scholar
  • 7 Schluger JH, Ho A, Borg L et al. Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol Clin Exp Res 1998; 22: 1430-1436
    CrossrefPubMedSearch in Google Scholar
  • 8 Adinoff B, Junghanns K, Kiefer F et al. Suppression of the HPA axis stress-response: implications for relapse. Alcohol Clin Exp Res 2005; 29: 1351-1355
    CrossrefPubMedSearch in Google Scholar
  • 9 Junghanns K, Backhaus J, Tietz U et al. Impaired serum cortisol stress response is a predictor of early relapse. Alcohol Alcohol 2003; 382: 189-193
    PubMedSearch in Google Scholar
  • 10 Junghanns K, Tietz U, Dibbelt L et al. Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol 2005; 401: 80-85
    PubMedSearch in Google Scholar
  • 11 Ray LA, Mackillop J, Leggio L et al. Effects of naltrexone on cortisol levels in heavy drinkers. Pharmacol Biochem Behav 2009; 91: 489-494
    CrossrefPubMedSearch in Google Scholar
  • 12 Kemper A, Koalick F, Thiele H et al. Cortisol and beta- endorphin response in alcoholics and alcohol abusers following a high naloxone dosage. Drug Alcohol Depend 1990; 25: 319-326
    CrossrefPubMedSearch in Google Scholar
  • 13 Volavka J, Mallya A, Bauman J et al. Hormonal and other effects of naltrexone in normal men. Adv Exp Med Biol 1979; 116: 291-305
    PubMedSearch in Google Scholar
  • 14 Farren CK, O’Malley S, Grebski G et al. Variable dose naltrexone-induced hypothalamic-pituitary-adrenal stimulation in abstinent alcoholics: a preliminary study. Alcohol Clin Exp Res 1999; 23: 502-508
    PubMedSearch in Google Scholar
  • 15 O’Malley SS, Krishnan-Sarin S, Farren C et al. Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis. Psychopharmacology 2002; 160: 19-29
    CrossrefPubMedSearch in Google Scholar
  • 16 American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th edition text revision Washington DC: American Psychiatric Association; 2000
    Search in Google Scholar
  • 17 Selzer ML. The Michigan Alcoholism Screening Test (MAST): The quest for a new diagnostic instrument. Am J Psychiatry 1971; 127: 1653-1658
    CrossrefPubMedSearch in Google Scholar
  • 18 Sullivan JT, Swift RM, Lewis DC. Benzodiazepine requirements during alcohol withdrawal syndrome: Clinical implications of using a standardized withdrawal scale. J Clin Psychopharmacol 1991; 11: 291-295
    PubMedSearch in Google Scholar
  • 19 Krishnan-Sarin S, Rounsaville BJ, O’Malley SS. Opioid receptor antagonists: Naltrexone and Nalmafene. In Sadock BJ, Sadock VA. editors. Kaplan&Sadock’s Comprehensive Texbook of Psychiatry. 8. Edition 2007
    Search in Google Scholar
  • 20 Martin del Campo AF, Dowson JH, Herbert J et al. Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man. Psychopharmacology 1994; 114: 583-590
    CrossrefPubMedSearch in Google Scholar
  • 21 Kiefer F, Jahn H, Otte C et al. Hypothalamic-pituitary-adrenocortical axis activity: a target of pharmacological anticraving treatment?. Biol Psychiatry 2006; 60: 74-76
    CrossrefPubMedSearch in Google Scholar
  • 22 Inder WJ, Joyce PR, Ellis MJ et al. The effects of alcoholism on the hypothalamic-pituitary-adrenal axis: Interaction with endogenous opioid peptides. Clin Endocrinol (Oxf) 1995; 43: 283-290
    CrossrefPubMedSearch in Google Scholar
  • 23 Adinoff B, Krebaum SR, Chandler PA et al. Dissection of hypothalamic-pituitary-adrenal axis pathology in 1-month-abstinent alcohol-dependent men, part 2: response to ovine corticotropin-releasing factor and naloxone. Alcohol Clin Exp Res 2005; 29: 528-537
    CrossrefPubMedSearch in Google Scholar
  • 24 Costa A, Bono G, Martignoni E et al. An assessment of hypothalamo-pituitary-adrenal axis functioning in non-depressed, early abstinent alcoholics. Psychoneuroendocrinology 1996; 21: 263-275
    CrossrefPubMedSearch in Google Scholar
  • 25 Lee S, Schmidt ED, Tilders FJ et al. Effect of repeated exposure to alcohol on the response of the hypothalamic-pituitary-adrenal axis of the rat: I. Role of changes in hypothalamic neuronal activity. Alcohol Clin Exp Res 2001; 25: 98-105
    CrossrefPubMedSearch in Google Scholar
  • 26 Ozsoy S, Esel E. Hypothalamic-pituitary-adrenal axis activity, dehydroepiandrosterone sulphate and their relationships with aggression in early and late alcohol withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 340-347
    CrossrefPubMedSearch in Google Scholar
  • 27 Ehrenreich H, Schuck J, Stender N et al. Endocrine and hemodynamic effects of stress versus systemic CRF in alcoholics during early and medium term abstinence. Alcohol Clin Exp Res 1997; 21: 1285-1293
    CrossrefPubMedSearch in Google Scholar
  • 28 Fries E, Hellhammer DH, Hellhammer J. Attenuation of the hypothalamic-pituitary-adrenal axis responsivity to the Trier Social Stress Test by the benzodiazepine alprazolam. Psychoneuroendocrinology 2006; 31: 1278-1288
    CrossrefPubMedSearch in Google Scholar